Press Releases Crossject

Equities

ALCJ

FR0011716265

Market Closed - Euronext Paris Other stock markets 11:35:23 2024-05-06 am EDT			5-day change	1st Jan Change
2.135 ^EUR	-4.26%		+3.39%	-57.04%

May. 03	Crossject: praised for extended agreement on Zepizure	CF
May. 02	Crossject Signs A Geographic Extension of ZEPIZURE Commercialization Agreement in Europe	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Crossject signs a geographic extension of ZEPIZURE® commercialization agreement in Europe	May. 02	GL
Crossject reports audited financial results for 2023	Apr. 25	GL
Crossject trading on Euronext to resume as usual on Wednesday April 3	Apr. 02	GL
Crossject advances in its U.S. Strategy and reports Financial Results for 2023	Apr. 02	GL
Crossject gender equality score reaches 96/100 in 2024	Mar. 08	GL
Crossject gender equality score reaches 96/100 in 2024	Mar. 08	AQ
Crossject obtains a financing up to €12 million, in two tranches	Feb. 27	GL
Crossject obtains a financing up to €12 million, in two tranches	Feb. 27	AQ
Crossject provides strategic update on priorities for 2024	Feb. 06	GL
Crossject provides strategic update on priorities for 2024	Feb. 06	AQ
Crossject to host a business briefing on commercial strategy on February 6 at 17:30 CET	Feb. 01	GL
Crossject to host a business briefing on commercial strategy on February 6 at 17:30 CET	Feb. 01	AQ
Crossject to present at Biotech Showcase on January 9 at 16:30 PT	Jan. 09	GL
Crossject engages Syneos Health for U.S. commercial launch of ZEPIZURE®	Jan. 04	GL
Crossject signs ZEPIZURE® commercialization agreement for northern Europe	Dec. 22	AQ
Crossject signs ZEPIZURE® commercialization agreement for northern Europe	Dec. 22	GL
Crossject announces initiation of coverage by ODDO BHF	Nov. 28	GL
Crossject announces initiation of coverage by ODDO BHF	Nov. 28	AQ
Crossject reports financial results and business highlights for first half of 2023	23-09-26	GL
Crossject reports financial results and business highlights for first half of 2023	23-09-26	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Crossject

Equities

ALCJ

FR0011716265

Press Releases

Filters